Home›Companies›Biotech & Pharma›EnPlusOne Biosciences

EnPlusOne Biosciences Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 26, 2024·Suggest an edit

About EnPlusOne Biosciences

EnPlusOne Biosciences is a private company based in Watertown, Massachusetts, incorporated in 2022 in Delaware. It has reported $21,816,706 raised in one offering on Form D since October 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 9, 2024Oct 3, 2022amended Dec 26, 2024$21,816,706of $23.1M target7$3.1MEquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EnPlusOne Biosciences's Form D filed Dec 26, 2024.

PM
Paxton Major
Director
AL
Andrew Lee
Director
SK
Steven Kasok
Director
DA
Daniel Ahlstedt
Chief OperatingOfficer and director

Sources

  1. SECEnPlusOne Biosciences Inc. Form D/A, filed Dec 26, 2024
  2. SECEnPlusOne Biosciences Inc. Form D, filed Oct 3, 2022
  3. SECEnPlusOne Biosciences Inc. filing history